| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 250.39 | 163 | 53.613 | 214.49 | 16.737 |
| Total Profit (Loss) | 64.92 | 53.91 | 20.422 | 53.28 | 21.846 |
| Profit (Loss) Operational | 35.54 | 34.33 | 3.524 | 31.04 | 14.497 |
| Net Profit (Loss) after Zakat and Tax | 21.31 | 23.58 | -9.626 | 19.93 | 6.924 |
| Total Comprehensive Income | 21.52 | 23.2 | -7.241 | 20.36 | 5.697 |
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Sales/Revenue | 665.56 | 519.94 | 28.007 |
| Total Profit (Loss) | 185.04 | 174.08 | 6.295 |
| Profit (Loss) Operational | 106.54 | 102.83 | 3.607 |
| Net Profit (Loss) after Zakat and Tax | 72.12 | 77.21 | -6.592 |
| Total Comprehensive Income | 72.69 | 76.49 | -4.967 |
| Total Share Holders Equity (after deducting minority equity) | 1,458.25 | 1,446.14 | 0.837 |
| Profit (Loss) per Share | 0.6 | 0.64 | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| Reason for increase (decrease) in net profit for current quarter compared to the same quarter of the previous year | The decrease in net profit in this quarter compared to the same quarter last year is due to: 1- The increase in finance costs associated with the increase in loans financing during the year to finance the operations of the company and the subsidiary. 2-The increase in the direct and indirect operating expenses associated with running Nuzha Hospotial branch opened in February of this year despite the increase in revenues generated from opening Nuzha Hospital and the increase in pharmaceutical products sales realized from the subsidiary Medical Support Services Company that has been acquired in the first quarter of the current year |
| Reason for increase (decrease) in net profit for current quarter compared to the previous quarter | The increase in net profit in this quarter compared to the previous quarter in the current year is due to increase in revenues generated from opening Nuzha Hospital and the increase in pharmaceutical products sales realized from the subsidiary Medical Support Services Company that has been acquired in the first quarter of the current year |
| Reason for increase (decrease) in net profit for current period compared to the similar period of the previous year | The decrease in net profit in this period compared to the same period last year is due to: 1- The increase in finance costs associated with the increase in loans financing during the year to finance the operations of the company and the subsidiary. 2-The increase in the direct and indirect operating expenses associated with running Nuzha Hospotial branch opened in February of this year despite the increase in revenues generated from opening Nuzha Hospital and the increase in pharmaceutical products sales realized from the subsidiary Medical Support Services Company that has been acquired in the first quarter of the current year. |
| Type of the external auditor's opinion | Unmodified opinion |
| Reclassifications in quarter financial result | 1- Certain disclosures and figures of the financial statements have been presented, classified and measured in accordance with IFRS 9 and 15. For more information, refer to note 4 (Summary of Significant Accounting Policies) attached to the condensed consolidated interim financial statements for the period ended 30 September 2018. |
2- This condensed consolidated interim financial statements incorporate the financial statements of the subsidiary (Medical Support Services Company) acquired during the first quarter of this year with the Company's financial statements. Therefore, the balances of the comparative figures do not include the balances or figures of the subsidiary.
3- Certain figures of the previous year have been reclassified to conform to the presentation for the current year presentation.
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.